Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

STDs (or STIs) are infections that can mostly be passed on to another person during sex, be it anal, oral or vaginal sex. There are different types of STDs, from very benign to malignant and harmful ones. Nearly 20 different infections are known to be transmitted through sexual contact. Most STDs affect both men and women, but in many cases the health problems they cause can be more severe for women. If a pregnant woman has an STD, it can cause serious health problems for the baby. More than 40 types of HPV can be spread sexually. If untreated, STIs can increase your risk of acquiring another STI such as HIV. Infectious diseases are caused by microorganisms such as viruses, bacteria, fungi or parasites and can spread between individuals. There are almost 217 types of infectious diseases among them some are such as 'Common cold' include a number of distinct pathogens. Many infectious diseases, such as measles and chickenpox, can be prevented by vaccines.


  • Track 1-1Replacement Feeding
  • Track 1-2Chlamydia
  • Track 1-3Gonorrhea
  • Track 1-4Genital Herpes
  • Track 1-5Syphilis
  • Track 1-6Human Papillomavirus
  • Track 1-7Viral Hepatitis
  • Track 1-8Molecular mechanisms of Viral Infection

Depending on the type of disease, STDs can be spread with any type of sexual activity. STDs are most often caused by viruses and bacteria, both bacterial and viral STDs vary in their treatment. Bacterial STDs, such as gonorrhea, syphilis, and chlamydia, are often cured with antibiotics. However, viral STDs, such as HIV, HPV (genital warts), herpes, and hepatitis (the only STD that can be prevented with a vaccine), have no cure, but their symptoms can be alleviated with treatment. STDs, such as gonorrhea and syphilis, are classified as "reportable" because when diagnosed they must be reported to a proper health or government agency to prevent their spread. Gonorrhea, one of the most widespread of the STDs, is caused by the bacterium Neisseria gonorrhoeae, some strains of which are resistant to treatment by penicillin as well as the other drugs of choice. 80 percent of women and 40 percent of men diagnosed with chlamydia may not experiencesymptoms.

  • Track 2-1Chancroid
  • Track 2-2Lymphogranuloma Venereum (LGV)
  • Track 2-3Nongonococcal Urethritis (NGU)
  • Track 2-4Pelvic Inflammatory Disease (PID)
  • Track 2-5Vaginitis
  • Track 2-6Viral Hepatitis
  • Track 2-7Cytomegalovirus
  • Track 2-8Herpes (HSV1 & HSV2)
  • Track 2-9Molluscum Contagiosum
  • Track 2-10Mononucleosis
  • Track 2-11Intestinal Parasites
  • Track 2-12Scabies
  • Track 2-13Cytomegalovirus (CMV)
  • Track 2-14Mycoplasma Genitalium 
  • Track 2-15Vaginosis
  • Track 2-16Yeast Infection
  • Track 2-17 Yeast in Men
  • Track 2-18Epstein Barr virus
  • Track 2-19Genital Warts

The syndromic approach is an important tool in the control of STIs and their sequelae, management by syndrome alone is inadequate because infections with important pathogens such as Chlamydia trachomatis and Neisseria gonorrhoeae may be present without any symptoms or findings. It is crucial to recognize syndromes that may be caused by one or more sexually transmitted pathogens and in managing STIs, diagnosis by syndrome and laboratory diagnosis by testing for specific organisms are both important and complementary. Diagnosis of a syndrome according to standard criteria predicts the likelihood that a specific pathogen or pathogens is/are present and thus facilitates initiation of appropriate empiric treatment at the first visit rather than deferring treatment until there is microbiological confirmation. WHO has developed simple flowcharts (also called algorithms) to guide health care providers in using the syndromic approach to manage seven syndromes.


  • Track 3-1Hepatitis(Inflammation of Liver)
  • Track 3-2Prostatitis(Inflammation of Prostate)
  • Track 3-3Sexually transmitted infection(STI)-related enteric infections
  • Track 3-4Cervicitis(Inflammation of Cervix)
  • Track 3-5Urethritis(Inflammation of Urethra)
  • Track 3-6Pelvic Inflammatory Disease

The sexually transmitted diseases Testing Market is forecast to reach $167.4 billion by 2020, registering a CAGR of 8.5% during 2014-2020. STDs are a grave issue globally, and are responsible for high morbidity in adults and cause infertility in both men and women. Diagnostic procedures of STDs market include the technologies that are used to identify and analyze STD along with the laboratories where the tests are carried out. Diagnostic testing programs are implemented by health care departments in developed regions for prevention and control of transmission, specifically of P&S Syphilis, Chlamydia, Gonorrhea and HPV. HPV testing volume and revenue will grow at much faster rate owing to higher incidences in Asia Pacific region.


  • Track 4-1Blood/Serum testing
  • Track 4-2PCR testing
  • Track 4-3POC testing
  • Track 4-4Immunochromatographic assays
  • Track 4-5Flow Cytometers
  • Track 4-6Differential Light Scattering machines
  • Track 4-7Phone chips
  • Track 4-8Rapid diagnostic kits
  • Track 4-9Absorbance microplate reader
  • Track 4-10CICT/PICT testing
  • Track 4-11CSF examination
  • Track 4-12Whiff test

Abnormal development of the fetus resulting in death, malformation, growth retardation, and functional disorders is defined as birth defects. Approximately 150,000 babies are born each year with birth defects. Birth defects, including low birth weight babies, are the leading cause of infant mortality. Chlamydia, among the most common sexually transmitted diseases, affects an estimated 100,000 pregnant women each year, according to the Centers for Disease Control and Prevention. In fact, it's one of the leading causes of infections affecting newborns' eyes and respiratory system. Exposure to the bacteria during childbirth could lead to infection of the respiratory tract, causing infant pneumonia. While some types of birth defects have decreased, mainly through preventive methods, many have increased. According to a CDC study of 38 types of birth defects occurring over the period 1979-89, 27 had increased, including several cardiac defects, chromosomal defects such as trisomy 18, and fetal alcohol syndrome; 9 had remained the same; and only 2 had decreased.Premature birth of the baby which happens before 37 weeks of the pregnancy.Birth defects which is the abnormal shapes and function of the baby.


  • Track 5-1Chromosomal abnormalities
  • Track 5-2Mutations
  • Track 5-3Functional abnormality
  • Track 5-4Affect of teratogens
  • Track 5-5Altered metabolism
  • Track 5-6Premature birth
  • Track 5-7Poor growth
  • Track 5-8Poor growth
  • Track 5-9Mental retardation
  • Track 5-10Genetic disorder
  • Track 5-11Low birth weight

Emerging Infectious Diseases are those whose incidence or geographic range is rapidly increasing or threatens to increase in the near future. The rise of new infectious diseases or the re-emergence of the old infectious diseases is favored by many factors like evolution of the pathogens, human behavior and practice.
The emerging diseases can be established by its introduction into a population and its ability to spread from one person to another. Many emerging and re-emerging infectious diseases have been discovered like Hemorrhagic fever, Encephalitis, Zika virus & West nile virus etc.


  • Track 6-1Hemorrhagic fever
  • Track 6-2Encephalitis
  • Track 6-3Yellow fever
  • Track 6-4Anthrax
  • Track 6-5Rabies
  • Track 6-6Rabies
  • Track 6-7Malaria and Chickungunya
  • Track 6-8Cardiovascular Diseases
  • Track 6-9Renal and Urologic Abnormalities
  • Track 6-10Measles
  • Track 6-11HIV & Polio virus
  • Track 6-12Zika virus & West nile virus

Having an STD/STI increases a person's risk for several types of cancer. Certain high-risk types of human papillomavirus (HPV) can cause cervical cancer in women and other cancers including cancer of the vulva, vagina. In men, HPV infection can lead to the development of penile cancers. HPV also can cause cancers of the mouth, throat, and anus in both sexes. It can also cause oropharyngeal cancer. Acquiring viral hepatitis B or C puts a person at risk for liver cancer, and untreated HIV/AIDS increases risk for several types of rare cancers, including lymphomas, sarcomas, and cervical cancer. There are HPV tests that can be used to screen for cervical cancer. These tests are recommended for screening only in women aged 30 years and older. They are not recommended to screen men, adolescents, or women under the age of 30 years.

  • Track 7-1Gastric Cancer
  • Track 7-2Cervical cancer
  • Track 7-3Penile cancers
  • Track 7-4Mouth and Throat cancers
  • Track 7-5Liver cancer(hepatitis B or C)
  • Track 7-6Lymphomas
  • Track 7-7Vulva, Vagina cancers
  • Track 7-8Oropharyngeal cancer
  • Track 7-9Sarcomas
  • Track 7-10Head and Neck cancer
  • Track 7-11Prostate Cancer
  • Track 7-12Prostate Cancer
  • Track 7-13Prostate Cancer

  • Track 8-1Acute and chronic infections
  • Track 8-2Pediatric tropical diseases
  • Track 8-3Pediatric parasitic diseases
  • Track 8-4Pediatric Tuberculosis
  • Track 8-5Blood infections
  • Track 8-6Antibiotic stewardship in pediatrics
  • Track 8-7Congenital and perinatal infections
  • Track 8-8Pediatric and adolescent HIV disease

STI epidemiology and management have evolved interactively, particularly in developing countries. Technological advances in diagnosis, screening, and treatment; evaluation and widespread implementation of new case-management algorithms; and changes in risk behaviors in response to the AIDS epidemic have all influenced the dynamic typology of STIs. Every year worldwide, there are approximately 357 million new infections of syphilis, chlamydia, gonorrhea, and trichomoniasis. A major recent advance in STI prevention is the early success of a prophylactic, monovalent human papillomavirus (HPV) type 16 vaccine, HPV vaccines may be able to help prevent genital and anal cancers in the foreseeable future.


  • Track 9-1Syndromic Management
  • Track 9-2Role of Core Groups
  • Track 9-3Antibiotic Use
  • Track 9-4Drug Resistance
  • Track 9-5Sexual Health Care
  • Track 9-6Social Risk Markers
  • Track 9-7Behavioral Risk Factors
  • Track 9-8Clinical interventions

Women who are pregnant can become infected with the same STDs as women who are not pregnant. Pregnancy does not provide women or their babies any additional protection against STDs. STDs can complicate the pregnancy and may have serious effects on both mother and the developing baby. STDs/STIs during pregnancy can also cause Miscarriage, Ectopic pregnancy, Preterm labor and delivery, Birth defects and Newborn death etc. Some of these problems may be seen at birth; others may not be discovered until months or years later. Testing and treating pregnant women for STDs is a vital way to prevent serious health complications to both mother and baby that may otherwise happen with infection. STDs, such as chlamydia, gonorrhea, syphilis, trichomoniasis and BV can all be treated and cured with antibiotics that are safe to take during pregnancy.

  • Track 10-1Types of STDs in pregnancy
  • Track 10-2Embryo/fetus affect
  • Track 10-3STDs affect in pregnancy
  • Track 10-4STDs affect in pregnancy
  • Track 10-5Risk of transmission
  • Track 10-6Antibiotics Treatment
  • Track 10-7Abstain
  • Track 10-8Antiviral medications
  • Track 10-9Antimicrobial drugs

Vaccines are the products that can produce immunity from a disease and can be administered through needle injections, by mouth and by aerosol. Vaccination is the injection of a killed or weakened organism that produces immunity in the body against that organism. Infectious Diseases Vaccines are the vaccines which prevent the Infectious Diseases and Infectious Diseases like Diphtheria, Hemophilic Influenzae Serotype B infection, HepatitisB, Measles,Meningitis, Mumps, Pertussis, Poliomyelitis, Rubella, Tetanus, Tuberculosis and Yellow Fever are preventable through vaccines.

Some STDs, such as such as gonorrhea, Chlamydia, and syphilis, are caused by bacteria. They are usually effectively treated with antibiotics. Several STDs can be effectively prevented through pre-exposure vaccination with widely available vaccines, including HAV, HBV, and HPV. Viral STDs are often highly persistent despite current therapeutic options or have no acceptable treatment available. Therefore, vaccines for certain viral STDs are in use, and others are in development.Researchers have developed vaccines for two sexually transmitted diseases. Ongoing efforts to develop vaccines for herpes and HIV may prove successful .

  • Track 11-1Polio vaccine
  • Track 11-2Tetanus vaccine
  • Track 11-3Gonorrhea and Chlamydia vaccines
  • Track 11-4Genital Herpes vaccines
  • Track 11-5HPV Vaccines
  • Track 11-6Gonorrhea and Chlamydia vaccines
  • Track 11-7Genital Herpes vaccine
  • Track 11-8HIV vaccines
  • Track 11-9Hepatitis A & B vaccine
  • Track 11-10Influenza (flu) vaccine
  • Track 11-11Varicella (chickenpox) vaccine
  • Track 11-12Tuberculosis (BCG Vaccine)
  • Track 11-13Tick-Borne Encephalitis vaccines
  • Track 11-14AIDS and Retroviral vaccines
  • Track 11-15Diphtheria vaccine
  • Track 11-16Varicella vaccine
  • Track 11-17Mumps vaccine

HIV can be transmitted from an HIV-positive woman to her child during pregnancy, childbirth and breastfeeding. Mother-to-child transmission (MTCT), which is also referred to as ‘vertical transmission’, accounts for the vast majority of new infections in children. Prevention of mother-to-child transmission (PMTCT) provide antiretroviral treatment (ART) to HIV-positive pregnant women to stop their infants from acquiring the virus.The World Health Organization (WHO) promotes a comprehensive approach to PMTCT programmes which includes:

  • Preventing new HIV infections among women of childbearing age
  • Preventing unintended pregnancies among women living with HIV
  • Preventing HIV transmission from a woman living with HIV to her baby
  • Providing appropriate treatment, care and support to mothers living with HIV and their children and families.

2.3 million HIV infections were discovered globally. Large part of the population discovered with HIV infection discovered was in their reproductive stage and the men and women diagnosed with HIV were likely to want children. Perinatal transmission of HIV, also called as Vertical Transmission, occurs when HIV is infected from HIV-positive women to her baby during pregnancy, labor and delivery or breastfeeding. The percentage of transmission ranges from 15 to 45% during pregnancy, labor and delivery. The rate of transmission increases to additional 35 to 45% when there is breast feeding by the mother to child. The transmission rate depends on the type of STD and the mode of transfer.

  • Track 12-1Maternal or Infant Antiretroviral Drugs
  • Track 12-2Prevention of mother-to-child transmission (PMTCT)
  • Track 12-3Voluntary Counselling and Testing
  • Track 12-4STD affects during pregnancy
  • Track 12-5Replacement Feeding
  • Track 12-6Early Infant diagnosis

Whether an infectious disease agent is an “old acquaintance” or a new, emerging threat, the immune system’s battle against it is usually the first line of defense it encounters. With vaccines and effective treatments often unavailable, the immune system’s efforts to eradicate infectious agents or infected cells are frequently the only means to combat them. pathology of infections not eradicated by the immune system early on and the cunning strategies of the infectious microbes to evade immune attacks is followed by sections on immunogenetics and exploration of the immune system’s interventions against two high-incidence infections, tuberculosis and AIDS.


  • Track 13-1Human Protein- Protein Interactions
  • Track 13-2Antigenic variations for pathogens
  • Track 13-3T helper cells response
  • Track 13-4Memory T cells response
  • Track 13-5Mechanism of action of Antibody response
  • Track 13-6Classical Immunology
  • Track 13-7Clinical Immunology
  • Track 13-8Computational Immunology
  • Track 13-9Immune System Disorders
  • Track 13-10Immunotherapy
  • Track 13-11Testicular Immunology
  • Track 13-12Viral Immunology

Effective new quality altering procedures guarantee noteworthy open doors for novel remedial alternatives to important illnesses, including cancer, genetic disorders and viral infections. Techniques like zinc finger nuclease, transcription activator-like effector nucleases and clustered regulatory interspaced short palindromic repeat.

  • Track 14-1Designer Nucleases approach
  • Track 14-2Gene manipulations approach
  • Track 14-3Anti HIV gene approach

With the newer diagnostic technologies, we are on the verge of a major change in the approach to STI control. When diagnostic methods are faster and results more accurate, they are bound to improve patient care. The molecular techniques are useful for microorganisms that are difficult to culture. They have a fairly recent history of just over 40 years. They are increasingly being accepted by clinicians as viable options in their practice. Aseptic technique is normally applied to prevent the infections caused by different means.


  • Track 15-1Molecular techniques
  • Track 15-2Pharmaceutical design of Drug and mechanism
  • Track 15-3Stem cell therapy
  • Track 15-4Antiviral drugs
  • Track 15-5Anti-Retroviral (ARV) Therapies and Vaccination
  • Track 15-6PER.C6 technology
  • Track 15-7AdVac Technology
  • Track 15-8LASER ART (long acting slow effective release antiretroviral therapy)

Infectious diseases prevention and control is helpful to prevent the transmission of infectious diseases. STI control efforts have increasingly been defined in relation to HIV programme priorities that are funded, implemented and evaluated independently of other STI control efforts. STI control is a public health outcome, measured as reduced incidence and prevalence, achieved by implementing strategies composed of multiple synergistic interventions. 

  • Track 16-1Infection control and cure
  • Track 16-2Ebola and Zika viral infections diagnosis and cure
  • Track 16-3Tuberculosis, Hepatitis and Malaria treatment and cure
  • Track 16-4Good hygienic practices
  • Track 16-5Abstinence
  • Track 16-6Mutual Monogamy
  • Track 16-7Alternative therapies

Sexually transmitted diseases(STDs) remain a major public health challenge in the world. Biological factors place women at greater risk than men for the severe health consequences of STDs. The two most commonly reported infectious diseases in America is chlamydia and gonorrhea which pose a particular risk to the health of women, as both can result in infertility if left untreated. Trends of STD are more toward viral origin as compare to bacterial origin. Epidemiology helped to develop methodology used in clinical research, public health studies and to a lesser extent basic research in the biological sciences

  • Track 17-1Modelling of infectious diseases
  • Track 17-2Chemicals and bulk drugs development
  • Track 17-3Pharmaceuticals
  • Track 17-4Devices and instruments
  • Track 17-5Drug formulation devices
  • Track 17-6Testing tools
  • Track 17-7Nano materials
  • Track 17-8Disinfection equipments
  • Track 17-9Technological Advancements for STDs diagnostic market
  • Track 17-10Market Dynamics

Ebola hemorrhagic caused by virus belonging to the family Filoviridae which is also called as Filovirus. This virus is also known as Zoonotic Virus as it is transmitted from animals to humans. This disease was first appeared in 1976 in 2 simultaneous outbreaks but the largest outbreak was discovered in West Africa which was also the most complex outbreak from the time it was discovered. Fruit bats of the Pteropodidae family are natural Ebola virus hosts the transmission is done from the by the close contact with the blood.

  • Track 18-1Ebola Outbreak
  • Track 18-2Ebola Epidemiology and advances
  • Track 18-3Molecular genetics of Ebola Virus
  • Track 18-4Molecular mechanisms of Ebola Virus Pathogenesis
  • Track 18-5Experimental Treatments for Ebola Viral Disease

The transfer of the pathogens causing the diseases can be form one person to another. But when the disease is transferred from animals to humans the disease is been termed as zoonotic diseases. The mode of transfer of the infectious agents can be in many ways like direct contact, indirect contact, vector-borne, food borne.

  • Routes of Transmission and Mechanism
  • Molecular genetic of Zoonotic Diseases
  • Symptoms and Drug treatment

  • Track 19-1Routes of Transmission and Mechanism
  • Track 19-2Molecular genetic of Zoonotic Diseases
  • Track 19-3Symptoms and Drug treatment

Sexually transmitted Infections (STIs) rank among the most important health issues for the people especially the young adults worldwide. The development of educational programs will play vital role in the fight to control sexually transmitted diseases. The Sexually Transmitted Disease (STD) infection prevention and control program works to reduce the incidence of sexually transmitted diseases. Social media practices to help implement awareness strategies. Awareness was generally high for HIV/AIDS (above 90%) and low for HPV (range 5.4%-66%). By providing screening, testing, diagnosis and treatment for infected individuals, the STD program is fighting the war against sexually transmitted diseases one person at a time. STDs can be simply prevented with three actions (a) Talk openly to partners, patients, and healthcare providers about sexual health and STDs, (b) Ensure everyone knows who should be tested and when, (c) The important role healthcare providers and patients play in making sure STDs are treated correctly.

  • Track 20-1Lifestyle and home remedies
  • Track 20-2Use of condom, safe sex
  • Track 20-3Educational programs
  • Track 20-4Avoid intravenous drugs
  • Track 20-5Clinical training
  • Track 20-6Screening Recommendations
  • Track 20-7Advanced treatments
  • Track 20-8Implement strategies